Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385698059> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W4385698059 abstract "<div>Abstract<p><i>PIK3CA</i> is the second most mutated gene in cancer leading to aberrant PI3K/AKT/mTOR signaling and increased translation, proliferation, and survival. Some 4%–25% of gastric cancers display activating <i>PIK3CA</i> mutations, including 80% of Epstein–Barr virus–associated GCs. Small molecules, including pan-PI3K and dual PI3K/mTOR inhibitors, have shown moderate success clinically, due to broad on-target/off-tissue effects. Thus, isoform-specific and mutant selective inhibitors have been of significant interest. However, drug resistance is a problem and has affected success of new drugs. There has been a concerted effort to define mechanisms of resistance and identify potent combinations in many tumor types, though gastric cancer is comparatively understudied. In this study, we identified modulators of the response to the PI3Kα-specific inhibitor, BYL719, in <i>PIK3CA</i>-mutant GCs. We found that loss of <i>NEDD9</i> or inhibition of BCL-XL conferred hypersensitivity to BYL719, through increased cell-cycle arrest and cell death, respectively. In addition, we discovered that loss of <i>CBFB</i> conferred resistance to BYL719. <i>CBFB</i> loss led to upregulation of the protein kinase PIM1, which can phosphorylate and activate several overlapping downstream substrates as AKT thereby maintaining pathway activity in the presence of PI3Kα inhibition. The addition of a pan-PIM inhibitor re-sensitized resistant cells to BYL719. Our data provide clear mechanistic insights into PI3Kα inhibitor response in <i>PIK3CA</i>-mutant gastric tumors and can inform future work as mutant-selective inhibitors are in development for diverse tumor types.</p>Implications:<p>Loss of either NEDD9 or BCL-XL confers hypersensitivity to PI3K-alpha inhibition whereas loss of CBFB confers resistance through a CBFB/PIM1 signaling axis.</p></div>" @default.
- W4385698059 created "2023-08-10" @default.
- W4385698059 creator A5001229101 @default.
- W4385698059 creator A5003742732 @default.
- W4385698059 creator A5044943844 @default.
- W4385698059 creator A5066575551 @default.
- W4385698059 creator A5072683967 @default.
- W4385698059 creator A5073973941 @default.
- W4385698059 creator A5081078513 @default.
- W4385698059 date "2023-08-09" @default.
- W4385698059 modified "2023-10-17" @default.
- W4385698059 title "Data from CBF-Beta Mitigates PI3K-Alpha–Specific Inhibitor Killing through PIM1 in <i>PIK3CA</i>-Mutant Gastric Cancer" @default.
- W4385698059 doi "https://doi.org/10.1158/1541-7786.c.6781964.v1" @default.
- W4385698059 hasPublicationYear "2023" @default.
- W4385698059 type Work @default.
- W4385698059 citedByCount "1" @default.
- W4385698059 countsByYear W43856980592023 @default.
- W4385698059 crossrefType "posted-content" @default.
- W4385698059 hasAuthorship W4385698059A5001229101 @default.
- W4385698059 hasAuthorship W4385698059A5003742732 @default.
- W4385698059 hasAuthorship W4385698059A5044943844 @default.
- W4385698059 hasAuthorship W4385698059A5066575551 @default.
- W4385698059 hasAuthorship W4385698059A5072683967 @default.
- W4385698059 hasAuthorship W4385698059A5073973941 @default.
- W4385698059 hasAuthorship W4385698059A5081078513 @default.
- W4385698059 hasConcept C104317684 @default.
- W4385698059 hasConcept C11960822 @default.
- W4385698059 hasConcept C121608353 @default.
- W4385698059 hasConcept C127561419 @default.
- W4385698059 hasConcept C143065580 @default.
- W4385698059 hasConcept C184235292 @default.
- W4385698059 hasConcept C185592680 @default.
- W4385698059 hasConcept C190283241 @default.
- W4385698059 hasConcept C2776414213 @default.
- W4385698059 hasConcept C502942594 @default.
- W4385698059 hasConcept C54355233 @default.
- W4385698059 hasConcept C55493867 @default.
- W4385698059 hasConcept C75217442 @default.
- W4385698059 hasConcept C86554907 @default.
- W4385698059 hasConcept C86803240 @default.
- W4385698059 hasConcept C98175054 @default.
- W4385698059 hasConceptScore W4385698059C104317684 @default.
- W4385698059 hasConceptScore W4385698059C11960822 @default.
- W4385698059 hasConceptScore W4385698059C121608353 @default.
- W4385698059 hasConceptScore W4385698059C127561419 @default.
- W4385698059 hasConceptScore W4385698059C143065580 @default.
- W4385698059 hasConceptScore W4385698059C184235292 @default.
- W4385698059 hasConceptScore W4385698059C185592680 @default.
- W4385698059 hasConceptScore W4385698059C190283241 @default.
- W4385698059 hasConceptScore W4385698059C2776414213 @default.
- W4385698059 hasConceptScore W4385698059C502942594 @default.
- W4385698059 hasConceptScore W4385698059C54355233 @default.
- W4385698059 hasConceptScore W4385698059C55493867 @default.
- W4385698059 hasConceptScore W4385698059C75217442 @default.
- W4385698059 hasConceptScore W4385698059C86554907 @default.
- W4385698059 hasConceptScore W4385698059C86803240 @default.
- W4385698059 hasConceptScore W4385698059C98175054 @default.
- W4385698059 hasLocation W43856980591 @default.
- W4385698059 hasOpenAccess W4385698059 @default.
- W4385698059 hasPrimaryLocation W43856980591 @default.
- W4385698059 hasRelatedWork W2026199302 @default.
- W4385698059 hasRelatedWork W2037154041 @default.
- W4385698059 hasRelatedWork W2049674776 @default.
- W4385698059 hasRelatedWork W2050167066 @default.
- W4385698059 hasRelatedWork W2168778208 @default.
- W4385698059 hasRelatedWork W2170799879 @default.
- W4385698059 hasRelatedWork W2328433417 @default.
- W4385698059 hasRelatedWork W2362061149 @default.
- W4385698059 hasRelatedWork W2744183625 @default.
- W4385698059 hasRelatedWork W4310004300 @default.
- W4385698059 isParatext "false" @default.
- W4385698059 isRetracted "false" @default.
- W4385698059 workType "article" @default.